Cytochrome P450, Family 2, Subfamily J, Polypeptide 2 (CYP2J2) Peptide
-
- Target See all CYP2J2 products
- CYP2J2 (Cytochrome P450, Family 2, Subfamily J, Polypeptide 2 (CYP2J2))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- EKVQAEIDRV IGQGQQPSTA ARESMPYTNA VIHEVQRMGN IIPLNVPREV
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CYP2 J2 antibody,
Alternative Names: CYP2J2 control peptide, CYP2J2 antibody Blocking Peptide, Anti-CYP2J2 Blocking Peptide, cytochrome P450, family 2, subfamily J, polypeptide 2 Blocking Peptide, CPJ2 Blocking Peptide, CYP2J2, CYPJ-2, CYPJ 2, CYPJ-2 Blocking Peptide, CYPJ 2 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- CYP2J2 (Cytochrome P450, Family 2, Subfamily J, Polypeptide 2 (CYP2J2))
- Background
- This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is thought to be the predominant enzyme responsible for epoxidation of endogenous arachidonic acid in cardiac tissue.
- Molecular Weight
- 57 kDa
-